Limited research does not suggest an increased chance preterm delivery delivery before 37 weeks of pregnancy or low birth weight when a woman takes methylphenidate as prescribed while pregnant. I need to take methylphenidate throughout my entire pregnancy.
Will it cause withdrawal symptoms in my baby after birth? Some babies exposed to stimulants close to the time of delivery may show temporary signs of withdrawal after they are born. Does taking methylphenidate in pregnancy cause long-term problems in behavior or learning for the baby? Limited studies have shown normal growth and development in children up to one year of age who were exposed to methylphenidate during pregnancy.
Methylphenidate passes into breast milk at low levels. When nursing mothers take it as prescribed, methylphenidate is not expected to cause problems for a nursing infant. Reports on five nursing infants, whose mothers were taking doses from mg per day, reported normal infant weight, sleeping and feeding habits. Talk to your healthcare provider about all of your breastfeeding questions.
If a man takes methylphenidate, could it affect his fertility ability to get his partner pregnant or increase the chance of birth defects?
There is no information to suggest that stimulants in semen increase the chance of birth defects. In general, exposures that fathers have are unlikely to increase risks to a pregnancy. Birth defects are common, costly, and critical conditions that affect 1 in every 33 babies born in the United States each year. Birth defects are structural changes present at birth that can affect almost any part or parts of the body such as the heart, brain, face, arms, and legs. They may affect how the body looks, works, or both.
Through Treating for Two , CDC is working with its partners, other federal agencies, and the public to understand trends in medication use among pregnant women and women of childbearing age and to provide women and healthcare providers with information about the safety or risk of using specific medications during pregnancy.
This information will allow women and their doctors to make informed decisions about treating health conditions during pregnancy. For more information, visit www. Journal of Attention Disorders. Skip directly to site content Skip directly to page options Skip directly to A-Z link. Exposure was defined as having redeemed 1 or more prescriptions for methylphenidate within a time window encompassing the first trimester.
The researchers included exposed and 2, unexposed pregnancies in the analysis. There was no statistically significant difference between the two groups in terms of risk for major malformations or cardiac malformations. In another report , researchers systematically reviewed available published data on birth outcomes in children with prenatal exposure to methylphenidate. They identified a total of children exposed to methylphenidate during the first trimester. Four children or 2. While these two reports are reassuring with regard to the risk of malformations, they did not include information on other outcomes, such as gestational age or birth weight.
In a small study, methylphenidate use during pregnancy was associated with increased risk of premature birth, growth retardation and neonatal withdrawal symptoms Debooy Unfortunately, this study included only 38 participants and was further confounded by the fact that these women were abusing methylphenidate and may have also used nicotine, alcohol and other drugs during their pregnancy.
0コメント